ARCHIVES

More Bad News for AVEO As Tivozanib Partner Bids Adieu

This article is from The Cancer Letter archive.

Vol. 39 No. 22 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

Lagging Government Salaries Spur NCI Turnover Among Senior Staff, Threaten Cancer Program

September 5, 1975

In Brief: Kennedy Seeing Comments On HAS Regulations; Shimkins History of Cancer Now Available

November 11, 1977

Cancer Prevention Fellowship Program Offers Enhancement

March 8, 1991

Report Redefines Cancer Control Research, Sets the Agenda For Newest NCI Division

October 17, 1997

Drugs and Targets: Blincyto granted accelerated approval in R/R ALL

December 5, 2014

FDA Approves Iressa For Third-Line Treatment Of Non-Small Cell Lung Cancer

May 9, 2003